BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
POT
Potash Corp Of Saskatchewan
POT
|
+$716M |
| 2 |
Apple
AAPL
|
+$677M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$561M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$554M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$497M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.85B |
| 2 |
Equinix
EQIX
|
+$2.31B |
| 3 |
Tesla
TSLA
|
+$2.3B |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$1.87B |
| 5 |
TRLA
TRULIA INC (DEL)
TRLA
|
+$1.64B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.8% |
| 2 | Financials | 3.08% |
| 3 | Industrials | 1.77% |
| 4 | Healthcare | 1.71% |
| 5 | Materials | 1.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Mativ Holdings
MATV
$662M
| $8.56K | ﹤0.01% |
196
+69
| +54% | +$2.9K |
|
|
CNL
2327
DELISTED
CLECO CRP (HOLDING CO)
CNL
| $8.43K | ﹤0.01% |
143
-7,351
| -98% | -$383K |
|
2328
SS&C Technologies
SSNC
$19B
| $8.4K | ﹤0.01% |
380
+270
| +245% | +$5.59K |
|
2329
VirnetX Holding Corp
VHC
$65.3M
| $8.4K | ﹤0.01% |
24
+19
| +380% | +$5.79K |
|
|
ROSE
2330
DELISTED
ROSETTA RESOURCES INC
ROSE
| $8.39K | ﹤0.01% |
153
-3,018
| -95% | -$147K |
|
2331
DexCom
DXCM
$34.2B
| $8.37K | ﹤0.01% |
844
+556
| +193% | +$4.93K |
|
|
PRXL
2332
DELISTED
Parexel International Corp
PRXL
| $8.35K | ﹤0.01% |
158
+114
| +259% | +$5.72K |
|
|
WRES
2333
DELISTED
WARREN RESOURCES INC
WRES
| $8.32K | ﹤0.01% |
1,342
+530
| +65% | +$2.57K |
|
2334
Gentherm
THRM
$1.34B
| $8.31K | ﹤0.01% |
+187
| New | +$7.36K |
|
|
ITIC
2335
Investors Title Co
ITIC
$536M
| $8.29K | ﹤0.01% |
+123
| New | +$8.54K |
|
2336
Forward Air
FWRD
$657M
| $8.18K | ﹤0.01% |
171
+129
| +307% | +$5.79K |
|
2337
iShares Global Consumer Staples ETF
KXI
$1.07B
| $8.18K | ﹤0.01% |
182
| – | – |
|
2338
HEICO Corp
HEI
$52B
| $8.1K | ﹤0.01% |
381
+12
| +3% | +$270 |
|
|
CMD
2339
DELISTED
Cantel Medical Corporation
CMD
| $8.09K | ﹤0.01% |
221
+118
| +115% | +$4K |
|
2340
Rollins
ROL
$17.4B
| $8.01K | ﹤0.01% |
901
-16,325
| -95% | -$147K |
|
2341
Acadia Pharmaceuticals
ACAD
$4.86B
| $7.97K | ﹤0.01% |
353
+287
| +435% | +$5.99K |
|
2342
Teledyne Technologies
TDY
$31.4B
| $7.97K | ﹤0.01% |
82
-61
| -43% | -$5.83K |
|
2343
Casey's General Stores
CASY
$31.7B
| $7.94K | ﹤0.01% |
113
-159
| -58% | -$11K |
|
2344
Uranium Energy
UEC
$5.64B
| $7.88K | ﹤0.01% |
5,050
-4,475
| -47% | -$6.34K |
|
|
EMCI
2345
DELISTED
EMC INS Group Inc
EMCI
| $7.85K | ﹤0.01% |
383
+92
| +32% | +$2.01K |
|
2346
Pricesmart
PSMT
$5.51B
| $7.83K | ﹤0.01% |
+90
| New | +$8.33K |
|
2347
CALL
Biogen
BIIB
$30.9B
| $7.8K | ﹤0.01% |
20
| – | – |
|
2348
Turkcell
TKC
$4.75B
| $7.8K | ﹤0.01% |
500
| – | – |
|
|
NPSP
2349
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $7.67K | ﹤0.01% |
232
-4,576
| -95% | -$132K |
|
2350
SPS Commerce
SPSC
$2.81B
| $7.65K | ﹤0.01% |
+242
| New | +$6.77K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2014 Portfolio in Review
As of Q2 2014, BNP Paribas Financial Markets held 4,108 positions worth $106B, down 17% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BNP Paribas Financial Markets deployed $44.2B of net new capital in Q2 2014, opening 765 new positions and adding to 1,315 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
By sector, the portfolio is most concentrated in Technology at 4.8% of assets, down from 26% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $3.85B trimmed.
- BNP Paribas Financial Markets's largest Q2 2014 buy was Canadian Pacific Kansas City: 15,162,685 shares worth $560M.
- BNP Paribas Financial Markets added most to Potash Corp Of Saskatchewan in Q2 2014, an estimated $716M increase.
- BNP Paribas Financial Markets's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $3.85B.
- BNP Paribas Financial Markets fully exited Walter Investment Mgt Corp in Q2 2014, selling an estimated $477M.
- BNP Paribas Financial Markets's ten largest holdings make up 42% of its $106B portfolio in Q2 2014.
- BNP Paribas Financial Markets opened 765 new positions and closed 285 in Q2 2014.
- BNP Paribas Financial Markets's portfolio value fell 17% quarter-over-quarter to $106B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2014, filed 14 Aug 2014.